Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 2c; Raises FY
Tweet Send to a FriendGet Alerts MYGN Hot Sheet
Trade MYGN Now!
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $119.2 million.
Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Semtech Corp (SMTC) Reports In-Line Q1 EPS, Offers Q2 Guidance
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
